Clinical trial Recruiting at 1 site Observational Ages 8 to 18

Diet and wearable monitoring of gut movement in children with IBS

Official title: The Role of Diet and Gastrointestinal Motility in Irritable Bowel Syndrome (IBS)

Run by Children's Hospital of Philadelphia · NCT07283341 · Data updated 2026-11-12

This project will use a wearable patch, diet recall, and stool and urine samples to see if certain foods, gut movement patterns, or microbes are linked to symptoms in children ages 8–18 with IBS.

More Irritable Bowel Syndrome (IBS) trials

Quick facts

Study typeObservational
Ages8 Years to 18 Years
SexAll
Enrollment90 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedJuly 31, 2023
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedDecember 15, 2025
Trial IDNCT07283341 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children 8–18 years old diagnosed with IBS whose parent/guardian can consent and who can tolerate a wearable adhesive patch and sample collection are ideal candidates.

Probably not a fit

Children with adhesive allergies, recent antibiotic use, inflammatory gastrointestinal disease, or inability to follow study procedures are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study enrolling children aged 8–18 with IBS and age-matched controls without abdominal pain. Participants will wear a wireless patch to record gut motility, complete questionnaires and a 24-hour dietary recall, and provide stool and urine samples for microbiome and metabolite analysis. Investigators will compare dietary patterns, motility signals, and microbial/metabolic profiles between children with and without IBS symptoms to identify links. Findings aim to help tailor diet-based approaches to relieve symptoms in pediatric IBS.

Why it matters

Potential benefit: If successful, the study could enable more personalized diet plans or monitoring strategies that reduce symptoms for children with IBS.

How similar studies have gone: Related research using wearable motility monitors and microbiome-diet analyses has shown promising associations, but pediatric personalized diet strategies remain largely unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Cases:

1. Males and females age 8 - 18 years
2. Diagnosis of irritable bowel syndrome (IBS).
3. Parental/guardian permission (informed consent) and child assent

Controls:

1. Males and Females age 8-18 years
2. No diagnosis of abdominal pain disorder
3. Parental/guardian permission (informed consent) and child assent

Exclusion Criteria:

Cases:

1. Allergy to adhesives
2. Inability to cooperate with study design
3. Antibiotic intake in the past 4 weeks
4. Inflammatory gastrointestinal disorder diagnosis

Controls:

1. Allergy to adhesives
2. Inability to cooperate with study design
3. Antibiotic intake in the past 4 weeks
4. Inflammatory gastrointestinal disorder diagnosis

Where it's running

  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Alain Benitez, MD, MSTR — Children's Hospital of Philadelphia, University of Pennsylvania
  • Study coordinator: Alain Benitez, MD, MSTR
  • Email: BenitezA@chop.edu
  • Phone: 215-590-1000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.